Akoya Biosciences Inc (AKYA) Business Payback Period

Corporate emblem and logo of Akoya (AKYA)

Akoya Biosciences dominates the spatial biology sector through PhenoCycler, which creates detailed maps of tumor zones for personalized treatment. This price chart on the GURU.Markets platform, where the indicator equals -1.30, visualizes this success. Akoya Biosciences generates revenue by supplying tissue analysis systems to pharmaceutical companies, creating a steady order flow and stable income from the sale of recurring consumables.

AKYA: Akoya Biosciences, Inc. P/E Multiple 07/04/2022 - 07/19/2025

Analytical breakdowns for akoyabio.com (AKYA)

- market price and analyst price targets:
Market Price akoyabio.com|AKYA - Price Target Chart
- market capitalization details:
Market Capitalization AKYA|AKYA - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Akoya Biosciences|AKYA - Book Capitalization|Market Capitalization to Book Value akoyabio.com|AKYA - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Akoya Biosciences|AKYA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital akoyabio.com|AKYA - Company Debts|Debt to Book Value Akoya Biosciences Inc|AKYA - Company Long-Term Debts|Short-Term Debt Akoya Biosciences|Immediate Liquidity Ratio akoyabio.com
- earnings and valuation multiples information:
AKYA - Net Profit|Company Profit Forecast Akoya Biosciences|AKYA - P/E Multiple|Projected Price to Earnings Akoya Biosciences|AKYA - PEG Multiple|EV/EBITDA Multiple Akoya|AKYA - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Akoya Biosciences|AKYA - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months akoyabio.com|AKYA - Earnings growth in current year|Expected net earnings per share growth next year Akoya Biosciences
- company sales and revenue statistics:
AKYA - Company Revenue|Company Sales Forecast Akoya Biosciences, Inc.|AKYA - Market Cap to Revenue|Forward P/S Multiple Akoya Biosciences Inc
Comprehensive company analysis:AKYA Akoya Biosciences, Inc.
Signature product of Akoya Biosciences

P/E reflects the market value of a single share relative to the business's share of net profit. This ratio measures the investment payback period, which is clearly demonstrated by the company's annual P/E. The current value of -1.30 allows for a comparison of the asset's valuation against US industry averages. A low level signals undervaluation, while an inflated one indicates a risk of correction. For Akoya Biosciences (AKYA), this metric confirms the capitalization of their closed spatial biology ecosystem.

Key competitors

Abbott Laboratories Inc. (ABT) - Business Payback Period|Price to Earnings Ratio TMO (Thermo Fisher)|Business Payback Period GE HealthCare|P/E Multiple MTD (mt.com)|Business Payback Period Waters Corporation (WAT)|Bio-Techne Corp - P/E Multiple|Business Payback Period Bruker BRKR|AZTA: P/E Multiple|Price to Earnings Ratio Varex Imaging|Price to Earnings Ratio SMLR|BFLY: Company Value to Net Income|Price to Earnings Ratio Mesa Laboratories Inc (MLAB)|QSI - Market Cap to Earnings|P/E Multiple NNOX (nanox.vision)|Quanterix Corp (QTRX) - Market Cap to Earnings|908 Devices - P/E Multiple|capsovision.com (CV) - Price to Earnings Ratio|MXCT: P/E Multiple|RPID - Business Payback Period|SEER (Seer Bio) - P/E Multiple|Price to Earnings Ratio Hyperfine Corp (HYPR)|P/E Multiple FONR|Price to Earnings Ratio DXR (Daxor Corp.)|Price to Earnings Ratio Spectral AI, Inc. MDAI|Organovo Holdings, Inc. - Price to Earnings Ratio|ACON: Price to Earnings Ratio|Company Value to Net Income THMO (ThermoGenesis Holdings Inc.)|TLIS: P/E Multiple|Market Cap to Earnings t2biosystems.com (TTOO)